Are you Dr. Reale?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 69 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
100 Haynes St
2nd Floor
Manchester, CT 06040Phone+1 860-646-0670Fax+1 860-643-9388
Summary
- Dr. Michael Reale, MD is an oncologist in Manchester, Connecticut. He is currently licensed to practice medicine in Connecticut, New York, and New Jersey. He is affiliated with Manchester Memorial Hospital, Rockville General Hospital, and Saint Francis Hospital and Medical Center.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1994
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1987 - 1990
Icahn School of Medicine at Mount SinaiClass of 1987
Certifications & Licensure
CT State Medical License 1990 - 2025
NJ State Medical License 2016 - 2025
NY State Medical License 2021 - 2023
Clinical Trials
- S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPolycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide.Constantin A Dasanu, Robert A. Schwartz, Frank Bauer, Lynn K Davis, Joel Silver
Leukemia Research. 2011-05-01 - 5 citationsMantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide.Constantin A Dasanu, Michael A. Reale, Frank Bauer
Leukemia Research. 2010-07-01 - 9 citationsTruncated DCC Reduces N-Cadherin/Catenin Expression and Calcium-Dependent Cell Adhesion in Neuroblastoma CellsMiguel Reyes-Múgica, Jeffrey A. Meyerhardt, Jessica Rzasa, David L. Rimm, Keith R. Johnson
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2001-02-01
Professional Memberships
- Member
